Trial: 201908037

Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (with Initial Phase I)

Phase

I/II

Principal Investigator

Baumann, Brian

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov